LES PEUPLES LIBRES

boyona1879 · Mer Juin 26, 2024 7:02 am

Phyllodes tumors are rare fibroepithelial neoplasms that occur in the breast. They account for less than 1% of all breast tumors, which makes them relatively uncommon. These tumors can present as palpable, fast-growing masses, and they can vary in size from small lesions to large, bulky growths. Unlike typical breast cancers, phyllodes tumors have a unique pattern of growth and a distinct histological appearance, characterized by a combination of stromal and epithelial components.

The clinical presentation of phyllodes tumors can be quite varied. Some patients may experience no symptoms and discover the tumor incidentally during routine breast examinations or imaging studies. Others may notice a rapidly enlarging breast mass, which can sometimes be accompanied by skin changes or ulceration. Due to their rapid growth, phyllodes tumors can sometimes be mistaken for other types of breast neoplasms, such as fibroadenomas.

Diagnosis of phyllodes tumors typically involves a combination of imaging studies and histopathological examination. Mammography and ultrasound are commonly used to evaluate the characteristics of the breast mass. However, definitive diagnosis often requires a biopsy, where a sample of the tumor tissue is examined under a microscope. Pathologists look for specific features, such as the degree of stromal cellularity and the presence of mitotic figures, to differentiate phyllodes tumors from other breast lesions.

Phyllodes tumors are classified into three categories: benign, borderline, and malignant. This classification is based on histological criteria, including the degree of stromal cellularity, mitotic activity, and the presence of stromal overgrowth. Benign phyllodes tumors are the most common type and have a relatively low risk of recurrence or metastasis. Borderline and malignant tumors, on the other hand, have a higher potential for local recurrence and, in rare cases, distant metastasis.

The treatment of phyllodes tumors primarily involves surgical excision. Wide local excision with clear margins is the preferred approach, as it reduces the risk of local recurrence. In some filloid tümör, a mastectomy may be necessary, especially for large tumors or those with malignant features. Adjuvant therapies, such as radiation or chemotherapy, are generally not used for phyllodes tumors, except in cases where the tumor has recurred or metastasized.

Despite the effectiveness of surgical treatment, phyllodes tumors have a tendency to recur. The risk of recurrence is higher for borderline and malignant tumors compared to benign ones. Regular follow-up with clinical and imaging evaluations is essential for early detection of recurrences. If a tumor does recur, additional surgical intervention is usually required.

Phyllodes tumors can present a significant psychological burden for patients, due to the fear of recurrence and the potential need for multiple surgeries. Supportive care and counseling may be beneficial to address these concerns. Additionally, patients may benefit from genetic counseling, as there is some evidence to suggest a hereditary component in certain cases.

Research on phyllodes tumors is ongoing, with efforts focused on understanding the molecular and genetic basis of these tumors. Advances in this area could lead to the development of targeted therapies and improved prognostic markers. Overall, while phyllodes tumors pose a clinical challenge due to their potential for recurrence, appropriate surgical management and vigilant follow-up can help ensure favorable outcomes for most patients.